Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07425249

Impact of Chewing Gum on Postoperative Gut Motility in Gastrointestinal Surgery Patients

Impact of Chewing Gum on Postoperative Gut Motility in Gastrointestinal Surgery Patients: A Randomized Controlled Trial at Khyber Teaching Hospital, Peshawar, Pakistan

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
Khyber Medical University Peshawar · Academic / Other
Sex
All
Age
17 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Postoperative ileus (POI) is a frequent complication after abdominal surgery, leading to delayed gastrointestinal motility, prolonged hospital stay, and increased patient discomfort. Chewing gum, as a form of sham feeding, has been proposed to stimulate gut motility through vagal stimulation and increased gastrointestinal secretions. This randomized controlled trial aims to assess the effect of chewing gum on early recovery of gastrointestinal motility in patients undergoing open gastrointestinal surgery.

Detailed description

This prospective randomized controlled trial will evaluate whether chewing gum reduces the time to return of bowel function after gastrointestinal surgery. Ninety-six adult patients undergoing open gastrointestinal surgery will be randomly allocated into intervention and control groups using block randomization. The intervention group will receive glucose-containing chewing gum starting six hours postoperatively. Outcomes measured include time to first bowel sounds, passage of flatus, and defecation. Statistical analysis will assess differences between groups to determine the efficacy of chewing gum in preventing postoperative ileus.

Conditions

Interventions

TypeNameDescription
BEHAVIORALChewing GumParticipants will chew glucose/carbohydrate-containing chewing gum for 15 minutes, three times daily, starting 6 hours after surgery and continuing for 48 hours or until the first passage of flatus or stool, in addition to standard postoperative care.

Timeline

Start date
2026-01-01
Primary completion
2026-08-25
Completion
2026-10-29
First posted
2026-02-20
Last updated
2026-02-20

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07425249. Inclusion in this directory is not an endorsement.